WO2005095631A3 - Diagnostics et therapies pour maladies associees a la kinase 4 alpha de lignee mixte (mlk4 alpha) - Google Patents
Diagnostics et therapies pour maladies associees a la kinase 4 alpha de lignee mixte (mlk4 alpha) Download PDFInfo
- Publication number
- WO2005095631A3 WO2005095631A3 PCT/EP2005/001600 EP2005001600W WO2005095631A3 WO 2005095631 A3 WO2005095631 A3 WO 2005095631A3 EP 2005001600 W EP2005001600 W EP 2005001600W WO 2005095631 A3 WO2005095631 A3 WO 2005095631A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- alpha
- mlk4
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04004816.7 | 2004-03-02 | ||
EP04004816 | 2004-03-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005095631A2 WO2005095631A2 (fr) | 2005-10-13 |
WO2005095631A3 true WO2005095631A3 (fr) | 2006-03-09 |
Family
ID=34961156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/001600 WO2005095631A2 (fr) | 2004-03-02 | 2005-02-17 | Diagnostics et therapies pour maladies associees a la kinase 4 alpha de lignee mixte (mlk4 alpha) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005095631A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2804335A1 (fr) * | 2010-06-15 | 2011-12-22 | Alberto Bardelli | Le gene mlk4, un nouveau marqueur de diagnostic et de pronostic des cancers |
-
2005
- 2005-02-17 WO PCT/EP2005/001600 patent/WO2005095631A2/fr active Application Filing
Non-Patent Citations (2)
Title |
---|
KVASHA S M ET AL: "Isolation, expression analysis and chromosomal mapping of a novel human kinase gene MLK4", BIOSIS, July 2001 (2001-07-01), XP002204714 * |
WANG L H ET AL: "Mixed-lineage kinases: A target for the prevention of neurodegeneration", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, ANNUAL REVIEW INC., PALO ALTO, CA, US, vol. 44, February 2004 (2004-02-01), pages 451 - 474, XP002329734, ISSN: 0362-1642 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005095631A2 (fr) | 2005-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006027147A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur d'adrenomedulline (amdr) | |
WO2006010517A3 (fr) | Diagnostic et traitement therapeutique des maladies associees a la proteine d'activation des fibroblastes (fap) | |
WO2005106491A3 (fr) | Diagnostic et traitement therapeutique de maladies associees a la kinase 1 regulee par serum/glucocorticoide (sgk1) | |
WO2005103684A3 (fr) | Diagnostics et methodes therapeutiqeus pour des maladies associees au recepteur 1 de la chimiokine cx3c | |
WO2005100990A3 (fr) | Methodes diagnostiques et therapeutiques pour des maladies associees au purinocepteur 2 de type y (p2y2) | |
WO2005022146A3 (fr) | Diagnostics et traitements de maladies associees a la kallikreine 13 (klk13) | |
WO2006010514A3 (fr) | Diagnostic et traitement therapeutique des maladies associees a la proteine kinase kinase 5 activee par les mitogenes (map2k5) a double specificite | |
WO2005085466A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees a la proteine kinase 2 associee a rho (rock2) | |
WO2005075675A3 (fr) | Outils de diagnostic et de traitement de maladies associees a la cysteine protease putative 1 (prsc1) | |
WO2005090994A3 (fr) | Diagnostic et therapeutique pour des maladies associees a la proteine kinase, dependante de cgmp, type 1 (prkg1) | |
WO2005113786A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre des maladies associees a la chymase (cma1) | |
WO2005095631A3 (fr) | Diagnostics et therapies pour maladies associees a la kinase 4 alpha de lignee mixte (mlk4 alpha) | |
WO2005085469A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees a la proteine kinase 1 associee a rho (rock1) | |
WO2005095953A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur de chimiokine c-c de type 6 (ccr6) | |
WO2005075983A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a un recepteur nucleaire humain nr4a3 (nr4a3) | |
WO2005073729A3 (fr) | Diagnostic et traitement de maladies associees au recepteur p2y11 couple a une proteine g (p2y11) | |
WO2006013013A3 (fr) | Agents pour le diagnostic et le traitement de maladies associees a la proteine protectrice pour la beta-galactosidase (ppgb) | |
WO2005106486A3 (fr) | Diagnostics et therapeutiques de maladies associees a la dipeptidyl-peptidase 3 (dpp3) | |
WO2005101004A3 (fr) | Diagnostics et therapeutiques pour des maladies associees au recepteur 1 de la purine de type y (p2y1) | |
WO2004104595A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a la x-pro dipeptidase (pepd) | |
WO2005075990A3 (fr) | Diagnostics et therapeutiques pour maladies associees au recepteur nucleaire humain nr4a2 (nr4a2) | |
WO2005118832A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl) | |
WO2006013012A3 (fr) | Diagnostics et therapeutique pour maladies liees a la napsine 1 (nap1) | |
WO2005026719A3 (fr) | Diagnostic et traitement de maladies associees au transporteur de cations organiques slc22a3 (slc22a3) | |
WO2005114209A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees a la kinase 2 specifique du recepteur couple a une proteine g (grk2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |